Linda A. Warnke

662 citations
11 papers · 555 indexed · h-index 11
Topics
Synthesis and biological activity (3 papers)Cancer, Hypoxia, and Metabolism (3 papers)Quinazolinone synthesis and applications (3 papers)

In The Last Decade

Linda A. Warnke

11 papers receiving 548 citations

Peers

Linda A. Warnke
Comparison fields: 5 of 91
  • Molecular Biology 198
  • Endocrinology, Diabetes and Metabolism 82
  • Organic Chemistry 82
  • Surgery 72
  • Cancer Research 71
Replace Yanhui Chu with:
Yanhui Chu China
Ralph A. Pietrofesa United States
Ru Sun China
Rafael Rodríguez‐Muñoz Mexico
Erwan Guyot France
Lulu Bai China
Flávio R. Palma United States
Isabelle Suc France
Sahori Yamazaki Japan
Wencan Wu China
Linda A. Warnke relative to Yanhui Chu China Yanhui Chu's profile →
Citations per field
00.5×5.5×
Yanhui Chu · 1×
Citations per year

Countries citing papers authored by Linda A. Warnke

Since Specialization
Citations

This map shows the geographic impact of Linda A. Warnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda A. Warnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda A. Warnke more than expected).

Fields of papers citing papers by Linda A. Warnke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda A. Warnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda A. Warnke. The network helps show where Linda A. Warnke may publish in the future.

Co-authorship network of co-authors of Linda A. Warnke

This figure shows the co-authorship network connecting the top 25 collaborators of Linda A. Warnke. A scholar is included among the top collaborators of Linda A. Warnke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda A. Warnke. Linda A. Warnke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 30
2 27
3 60
4 43
5 182
6 35
7 10
8 19
9 48
10 58
11 43

About Linda A. Warnke

Linda A. Warnke is a scholar working on Clinical Biochemistry, Neurology and Ophthalmology, having authored 11 papers that have together received 555 indexed citations. Recurring topics across this work include Synthesis and biological activity (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Quinazolinone synthesis and applications (3 papers). The work is most often cited by research in Clinical Biochemistry (52 citations), Environmental Chemistry (57 citations) and Endocrinology, Diabetes and Metabolism (82 citations). Linda A. Warnke has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Michael A. Ihnat, Jessica E. Thorpe, Chandrashekhar D. Kamat, Antonio Ceriello, Dixy E. Green, Joshua W. Hamilton, Ludovica Piconi, Ronald C. Kaltreider, Csaba Szabó and Zsombor Lacza. Their work appears in journals such as Diabetologia, Cancer Letters and Toxicological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026